Rare Diseases Activities
Achieving High-Quality Patient Outcomes in Spinal Muscular Atrophy: A Review of New Data and Managed Care Strategies
0290-0000-21-022-H01-P
This CE supplement will determine gold standards for treating spinal muscular atrophy (SMA) including updates to the 2020 revised recommendations.
2.00
Amyotrophic Lateral Sclerosis: Managed Care Considerations and Updates on Recent Clinical and Real-World Data
0290-0000-21-007-H01-P
This discussion among panelists will examine real-world cost and resource utilization data for approved ALS treatments.
1.50
Opportunities to Optimize Care in Pulmonary Arterial Hypertension
0290-0000-21-014-L01-P
This live webinar will examine different treatment paradigms implemented to improve patient care and treatment outcomes in PAH.
4-22-2021
1.00
Available Therapies for Atypical Hemolytic Uremic Syndrome: The Roles of Specialty and Infusion Pharmacists
0290-0000-20-288-H01-P
This activity will express the incidence, etiology, and clinical presentation associated with atypical hemolytic uremic syndrome (aHUS).
1.00